Showing results (181-190 of 498) with videos related to

Sort By:
Pageof 50
Frontiers in Oncology|August 27, 2019
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical AdvancesIrene Della Starza, Sabina Chiaretti, Maria S De Propris, et al.
Haematologica|March 7, 2007
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trialAntonella Vitale, Anna Guarini, Cristina Ariola, et al.
Haematologica|September 18, 2012
Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the diseaseMarilisa Marinelli, Nadia Peragine, Valeria Di Maio, et al.
Blood Advances|August 31, 2022
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study resultsUlrich Jaeger, Nina Worel, Joseph P McGuirk, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2011
The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: a joint analysis of five randomised trials on behalf of the EWALLSebastian Giebel, Xavier Thomas, Helene Hallbook, et al.
Haematologica|August 4, 2006
Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemiaMauro Krampera, Omar Perbellini, Carlo Vincenzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphomaMarkus Raderer, Stefan Wöhrer, Rupert Bartsch, et al.
Blood|April 24, 2009
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 casesIlaria Del Giudice, Sabina Chiaretti, Simona Tavolaro, et al.
Blood Cancer Journal|January 4, 2023
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF studyNicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, et al.
Blood|December 23, 2008
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotypeAlessandra Soriani, Alessandra Zingoni, Cristina Cerboni, et al.
Pageof 50